Raman and SERS identification of a combination prescribed opioid

Importance of the Topic

Onsite and rapid identification of active ingredients in combination pharmaceuticals is critical for controlled substance management and law enforcement. Handheld Raman devices offer a nondestructive means to detect major components, while surface-enhanced Raman spectroscopy (SERS) enables trace analysis of minor or potentially harmful constituents.

Objectives and Study Overview

This application demonstrates dual analysis of a prescription tablet containing acetaminophen and hydrocodone. The goals are to:

• Identify the bulk component using Raman spectroscopy.
• Detect low-level opioid content via SERS.

Methodology and Instrumentation

Sample preparation and analysis steps:

• Raman analysis with Metrohm MIRA DS Advanced and Long Working Distance (LWD) Smart Tip to penetrate tablet coating.
• SERS analysis by dissolving the tablet in methanol, mixing with gold colloid and salt, then measuring with the Vial Holder Smart Tip.

The key instruments and accessories used include:

• MIRA DS Advanced handheld Raman spectrometer with ORS technology.
• LWD attachment lens for point-and-shoot measurements.
• SERS ID Kit with Au nanoparticle colloid.

Main Results and Discussion

Raman spectra of the intact tablet matched the acetaminophen library spectrum with a high Hit Quality Index, confirming the bulk composition. Subsequent SERS measurements revealed spectral peaks corresponding to hydrocodone, enabling trace-level opioid detection. This combined approach allows identification of both major and minor constituents in a single analysis.

Raman sampling is effective for non-contact, through-container screening, while SERS provides enhanced sensitivity for low-concentration analytes and fluorescence-prone substances.

Benefits and Practical Applications

This dual-mode method:

• Enables rapid, field-deployable screening of pharmaceuticals and illicit substances.
• Reduces sample handling and contamination risks.
• Supports law enforcement, regulatory, and medical applications to curb prescription drug abuse.

Future Trends and Applications

Advances may include integration with larger spectral libraries for novel synthetic opioids, miniaturization of SERS substrates for improved portability, and automated workflows for non-technician users. Coupling with data-driven algorithms could further enhance detection limits and substance discrimination.

Conclusion

The combined use of handheld Raman and SERS analyses on Metrohm’s MIRA DS allows comprehensive identification of both bulk and trace components in combination pharmaceuticals. This streamlined approach enhances accuracy and speed in field and laboratory settings, offering a versatile tool against misuse of controlled substances.

References

• No references were provided in the source text.